Role of autophagy in the clearance of mutant huntingtin: A step towards therapy?

This publication has 31 references indexed in Scilit:

• Rapamycin alleviates toxicity of different aggregate-prone proteins
  Human Molecular Genetics, 2005
• Inefficient degradation of truncated polyglutamine proteins by the proteasome
  The EMBO Journal, 2004
• Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
  Nature, 2004
• The ubiquitin proteolytic system and pathogenesis of human diseases: a novel platform for mechanism-based drug targeting
  Biochemical Society Transactions, 2003
• Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease
  Proceedings of the National Academy of Sciences, 2000
• The Influence of Huntingtin Protein Size on Nuclear Localization and Cellular Toxicity
  The Journal of cell biology, 1998
• Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation
  Cell, 1997
• The Phosphatidylinositol 3‐Kinase Inhibitors Wortmannin and LY294002 Inhibit Autophagy in Isolated Rat Hepatocytes
  European Journal of Biochemistry, 1997
• RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.
  Proceedings of the National Academy of Sciences, 1994
• A mammalian protein targeted by G1-arresting rapamycin–receptor complex
  Nature, 1994